Desloratadine + Placebo
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Allergic Airway Disease
Conditions
Allergic Airway Disease
Trial Timeline
Jul 1, 2003 → Nov 1, 2004
NCT ID
NCT00779636About Desloratadine + Placebo
Desloratadine + Placebo is a approved stage product being developed by Organon for Allergic Airway Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00779636. Target conditions include Allergic Airway Disease.
What happened to similar drugs?
20 of 20 similar drugs in Allergic Airway Disease were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01916967 | Phase 3 | Completed |
| NCT00779636 | Approved | Completed |
| NCT00757562 | Phase 3 | Completed |
Competing Products
20 competing products in Allergic Airway Disease